Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
301 articles
Review reveals how PQQ supplement protects neurons via antioxidant, mitochondrial, and anti-inflammatory mechanisms in neurodegenerative diseases.
New research explores how combining multiple supplements could offer breakthrough treatments for brain diseases like Alzheimer's and Parkinson's.
Researchers identify transthyretin (TTR) as a potential biomarker for postoperative cognitive dysfunction, offering new diagnostic hope.
New study reveals how the locus coeruleus, a tiny brainstem region, affects cognitive practice effects in aging.
New research reveals how the APOE4 gene causes brain network dysfunction years before Alzheimer's disease symptoms develop.
New study reveals brain blood vessel aging as key driver of memory loss, with senolytic drugs showing promise for reversal.
Comprehensive review of 2021-2025 proteomics reveals 866 consensus protein changes and novel therapeutic targets in Alzheimer's disease.
Researchers identify 25 cerebrospinal fluid proteins that better predict amyloid and tau pathology stages than current biomarkers.
Breakthrough research shows myelin damage starts years before MS symptoms, opening new possibilities for early detection and intervention.
16-week ketogenic diet study shows sex-specific microbiome and brain metabolite changes in APOE4 mice, with greatest benefits in females.
New study reveals gut microbiome disruption in Alzheimer's patients and shows 12-week probiotic treatment reduces inflammation.
Home sleep monitoring reveals reduced REM sleep and total sleep time increase psychosis risk in Parkinson's patients.
